Variant report
Variant | esv17214 |
---|---|
Chromosome Location | chr4:90562958-90563578 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MMRN1-2 | chr4:90563568-90563671 | ENSG00000251095.1 |
2 | lnc-MMRN1-2 | chr4:90563568-90563671 | ENSG00000251095.1 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192855050 | chr4:90562984-90562985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544737571 | chr4:90563031-90563032 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560096069 | chr4:90563054-90563055 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577757979 | chr4:90563057-90563058 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527262438 | chr4:90563108-90563109 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547329750 | chr4:90563109-90563110 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs80306518 | chr4:90563157-90563158 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537563560 | chr4:90563165-90563166 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529588956 | chr4:90563206-90563207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557227150 | chr4:90563209-90563210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574198493 | chr4:90563267-90563268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369653490 | chr4:90563276-90563277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs116261917 | chr4:90563290-90563291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533478566 | chr4:90563306-90563307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542920622 | chr4:90563312-90563313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185761846 | chr4:90563348-90563349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560126032 | chr4:90563394-90563395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs17015961 | chr4:90563398-90563399 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs571207924 | chr4:90563427-90563428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113759979 | chr4:90563445-90563446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190246679 | chr4:90563450-90563451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564078581 | chr4:90563456-90563457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566464580 | chr4:90563457-90563458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537737191 | chr4:90563481-90563482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555948532 | chr4:90563498-90563499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs150474521 | chr4:90563521-90563522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545109454 | chr4:90563534-90563535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553549477 | chr4:90563564-90563565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs17015966 | chr4:90563568-90563569 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:90562600-90563000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr4:90562600-90566200 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
3 | chr4:90562800-90563000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr4:90562800-90563000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr4:90562800-90563200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr4:90562800-90563200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr4:90562800-90566000 | Weak transcription | HepG2 | liver |
8 | chr4:90563000-90563200 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |